Hypothesis
Morning blue‑light exposure not only advances the SCN clock via ipRGCs but also triggers a transient rise in mitochondrial reactive oxygen species (ROS) in cortical neurons that potentiates PER2 phosphorylation, thereby speeding up the molecular reset of the circadian oscillator.
Mechanistic Basis
Blue light activates ipRGCs, releasing glutamate and PACAP onto SCN neurons. This excitatory drive increases cytosolic Ca2+, which stimulates NADPH oxidase activity and modestly elevates mitochondrial ROS. ROS at low concentrations act as second messengers that activate CaMKII and MAPK pathways, leading to increased phosphorylation of PER2 at serine 659—a site known to accelerate PER2 degradation and phase advance. In parallel, ROS‑dependent inhibition of GSK3β stabilizes BMAL1‑CLOCK transcription, sharpening the amplitude of the reset. This dual action creates a feed‑forward loop where light‑induced ROS amplifies the canonical photic signaling cascade, making the phase‑shifting response more robust and faster than light alone predicts.
Predictions & Experimental Design
- Pharmacological test – Applying the ROS scavenger N‑acetylcysteine (NAC) to mouse SCN slices during a 30‑min, 1000 lux blue‑light pulse it's expected to reduce PER2‑Ser659 phosphorylation by >40 % and halve the phase‑advance magnitude measured by PER2::LUC bioluminescence.
- Genetic test – Neuron‑specific overexpression of mitochondrial-targeted catalase (mCAT) in excitatory SCN neurons will blunt the ROS surge and attenuate the advance, whereas knockdown of SOD2 will exaggerate it





























